Vincristine and intestinal pseudo-obstruction in children: Report of 5 cases, literature review, and suggested management

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 4, 2010, Pages e126-e130

  Diezi, Manuel ^a   Nydegger, Andreas ^a   Di Paolo, Ermindo R ^a   Kuchler, Henri ^a   Beck Popovic, Maja ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antifungals; Chemotherapy side effects; Neurotoxicity; Pharmacogenetics; Vincristine

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISAPRIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; ERYTHROMYCIN; ETOPOSIDE; IFOSFAMIDE; ITRACONAZOLE; LAXATIVE; LIQUID PARAFFIN; MACROGOL; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; METOCLOPRAMIDE; METRONIDAZOLE; OMEPRAZOLE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE LYMPHOBLASTIC LEUKEMIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALGORITHM; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B CELL LEUKEMIA; CHILD; CLINICAL ARTICLE; CONSTIPATION; DECREASED APPETITE; DIARRHEA; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ERYTHEMA; FEMALE; HODGKIN DISEASE; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INTESTINE PSEUDOOBSTRUCTION; LIVER FAILURE; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; RASH; SIDE EFFECT; T CELL LEUKEMIA; VOMITING; WEIGHT REDUCTION; ADOLESCENT; CASE REPORT; CHEMICALLY INDUCED DISORDER; KIDNEY TUMOR; PRESCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ALGORITHMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; FEMALE; HODGKIN DISEASE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; KIDNEY NEOPLASMS; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE; WILMS TUMOR;

EID: 77952765007     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181d7742f     Document Type: Article

References (41)

1. Antonucci A, Fronzoni L, Cogliandro L, et al. Chronic intestinal pseudo-obstruction. World J Gastroenterol. 2008; 14: 2953-2961.
2. Connor FL, Di LC. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006; 130(2 suppl 1): S29-S36.
3. Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemias. Cancer Res. 1963; 23: 613-621.
4. Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol. 1995; 40: 523-530.
5. Tsuruo T, Iida J, Tsukagoshi S, et al. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982; 42: 4730-4733.
6. Zhou-Pan XR, Seree E, Zhou XJ, et al. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions. Cancer Res. 1993; 53: 5121-5126.
7. Dennison JB, Jones DR, Renbarger JL, et al. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes. J Pharmacol Exp Ther. 2007; 321: 553-563.
8. Dennison JB, Kulanthaivel P, Barbuch RJ, et al. Selective metabolism of vincristine in vitro by CYP3A5. Drug Metab Dispos. 2006; 34: 1317-1327.
9. Ariffin H, Omar KZ, Ang EL, et al. Severe vincristine neurotoxicity with concomitant use of itraconazole. J Paediatr Child Health. 2003; 39: 638-639.
10. Bermudez M, Fuster JL, Llinares E, et al. Itraconazole-related increased vincristine neurotoxicity: case report and review of literature. J Pediatr Hematol Oncol. 2005; 27: 389-392.
11. Stones DK. Vincristine overdosage in paediatric patients. Med Pediatr Oncol. 1998; 30: 193.
12. Tomomasa T, Miyazawa R, Kato M, et al. Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine. Dig Dis Sci. 1999; 44: 1755-1757.
13. Goldstein B, Lhuillier M. Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine. Ann Med Interne (Paris). 1974; 125: 571-576.
14. Lorini R, Larizza D, Garibaldi E, et al. Paralytic ileus, convulsions and depressed blood sodium during treatment of a case of ALL with vincristine. Minerva Pediatr. 1977; 29: 1733-1738.
15. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002; 249: 9-17.
16. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol. 1986; 1: 421-427.
17. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. Neurology. 1969; 19: 367-374.
18. Rosenberg RF, Caridi JG. Vincristine-induced megacolon. Gastrointest Radiol. 1983; 8: 71-73.
19. Toghill PJ, Burke JD. Death from paralytic ileus following vincristine therapy. Postgrad Med J. 1970; 46: 330-331.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-245.
21. Owellen RJ, Root MA, Hains FO. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 1977; 37(8 Pt 1): 2603-2607.
22. Quaranta S, Chevalier D, Allorge D, et al. Ethnic differences in the distribution of CYP3A5 gene polymorphisms. Xenobiotica. 2006; 36: 1191-1200.
23. Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Pharmacotherapy. 1998; 18: 1304-1307.
24. Zhou SF, Xue CC, Yu XQ, et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007; 29: 687-710.
25. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002; 100: 1957-1964.
26. Eliasson E. Ethnicity and adverse drug reactions. BMJ. 2006; 332: 1163-1164.
27. Hammond IW, Ferguson JA, Kwong K, et al. Hyponatremia and syndrome of inappropriate anti-diuretic hormone reported with the use of Vincristine: an over-representation of Asians? Pharmacoepidemiol Drug Saf. 2002; 11: 229-234.
28. Huang RS, Murry DJ, Foster DR. Role of xenobiotic efflux transporters in resistance to vincristine. Biomed Pharmacother. 2008; 62: 59-64.
29. Kishi S, Yang W, Boureau B, et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood. 2004; 103: 67-72.
30. Hoffmeyer S, Burk O, von RO, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000; 97: 3473-3478.
31. Renbarger JL, McCammack KC, Rouse CE, et al. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr Blood Cancer. 2008; 50: 769-771.
32. Plasschaert SL, Groninger E, Boezen M, et al. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther. 2004; 76: 220-229.
33. Ulrich RG. Idiosyncratic toxicity: a convergence of risk factors. Annu Rev Med. 2007; 58: 17-34.
34. Harris AC, Jackson JM. Lactulose in vincristine-induced constipation. Med J Aust. 1977; 2: 573-574.
35. Garewal HS, Dalton WS. Metoclopramide in vincristine-induced ileus. Cancer Treat Rep. 1985; 69: 1309-1311.
36. Jackson DV Jr, Wu WC, Spurr CL. Treatment of vincristine-induced ileus with sincalide, a cholecystokinin analog. Cancer Chemother Pharmacol. 1982; 8: 83-85.
37. Ikehara O. Vincristine-induced paralytic ileus: role of fiberoptic colonoscopy and prostaglandin F2 alpha. Am J Gastroenterol. 1992; 87: 207-210.
38. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology. 1998; 115: 370-380.
39. Lyford G, Foxx-Orenstein A. Chronic intestinal pseudoobstruction. Curr Treat Options Gastroenterol. 2004; 7: 317-325.
40. Itoh Z. Motilin and clinical application. Peptides. 1997; 18: 593-608.
41. Maganti K, Onyemere K, Jones MP. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol. 2003; 98: 259-263.